Location: Westmont, IL
CIK: 0002050709 · Show all filings
Period: Q4 2025 (Next →)
Filing Date: Feb 17, 2026
Total Value: $236M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | 6,700,000 | $32.36M | 13.7% | $4.83 * | $3.35 | 0.0% | COM | 75955J402 |
| COGT | COGENT BIOSCIENCES INC | 780,000 | $27.71M | 11.7% | $35.52 * | $28.11 | 0.0% | COM | 19240Q201 |
| MAZE | MAZE THERAPEUTICS INC | 490,000 | $20.3M | 8.6% | $41.43 * | $34.37 | 0.0% | COM | 578784100 |
| ABVX | ABIVAX SA | 145,000 | $19.55M | 8.3% | $134.85 | $134.85 | — | SPONSORED ADS | 00370M103 |
| KALV | KALVISTA PHARMACEUTICALS INC | 700,000 | $11.3M | 4.8% | $16.15 * | $13.24 | 0.0% | COM | 483497103 |
| PALI | PALISADE BIO INC | 4,500,000 | $10.57M | 4.5% | $2.35 * | $1.92 | 0.0% | COM | 696389402 |
| EWTX | EDGEWISE THERAPEUTICS INC | 350,000 | $8.685M | 3.7% | $24.82 * | $20.07 | 0.0% | COM | 28036F105 |
| IKT | INHIBIKASE THERAPEUTICS INC | 4,225,000 | $8.661M | 3.7% | $2.05 * | $1.59 | 0.0% | COM NEW | 45719W205 |
| KOD | KODIAK SCIENCES INC | 291,710 | $8.156M | 3.5% | $27.96 * | $20.48 | 0.0% | COM | 50015M109 |
| TERN | TERNS PHARMACEUTICALS INC | 190,000 | $7.676M | 3.3% | $40.40 * | $23.11 | 0.0% | COM | 880881107 |
| AVBP | ARRIVENT BIOPHARMA INC | 338,000 | $6.801M | 2.9% | $20.12 | — | — | Call | 04272N102 |
| TARS | TARSUS PHARMACEUTICALS INC | 80,000 | $6.55M | 2.8% | $81.88 * | $74.67 | 0.0% | COM | 87650L103 |
| UPB | UPSTREAM BIO INC | 230,650 | $6.262M | 2.7% | $27.15 * | $24.89 | 0.0% | COM | 91678A107 |
| SPRB | SPRUCE BIOSCIENCES INC | 70,000 | $6.098M | 2.6% | $87.11 * | $107.14 | 0.0% | COM NEW | 85209E208 |
| XENE | XENON PHARMACEUTICALS INC | 105,551 | $4.731M | 2.0% | $44.82 * | $42.00 | 0.0% | COM | 98420N105 |
| DBVT | DBV TECHNOLOGIES S A | 240,000 | $4.601M | 1.9% | $19.17 | $19.17 | — | SPONSORED ADS | 23306J309 |
| HELP | CYBIN INC | 525,000 | $4.295M | 1.8% | $8.18 * | $6.44 | 0.0% | COM NEW | 23256X407 |
| LPCN | LIPOCINE INC NEW | 530,000 | $4.256M | 1.8% | $8.03 * | $3.36 | 0.0% | COM NEW | 53630X203 |
| BLTE | BELITE BIO INC | 26,000 | $4.159M | 1.8% | $159.96 | $159.96 | — | SPONSORED ADS | 07782B104 |
| GHRS | GH RESEARCH PLC | 315,000 | $4M | 1.7% | $12.70 * | $13.62 | 0.0% | ORDINARY SHARES | G3855L106 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 500,000 | $3.775M | 1.6% | $7.55 * | $6.16 | 0.0% | COM | 29842P105 |
| VTYX | VENTYX BIOSCIENCES INC | 410,000 | $3.702M | 1.6% | $9.03 * | $7.47 | 0.0% | COM | 92332V107 |
| NXTC | NEXTCURE INC | 236,966 | $3.363M | 1.4% | $14.19 * | $10.36 | 0.0% | COM NEW | 65343E207 |
| VERA | VERA THERAPEUTICS INC | 60,000 | $3.038M | 1.3% | $50.64 | — | — | Call | 92337R101 |
| WVE | WAVE LIFE SCIENCES LTD | 175,000 | $2.975M | 1.3% | $17.00 * | $10.16 | 0.0% | SHS | Y95308105 |
| KTTA | PASITHEA THERAPEUTICS CORP | 2,100,000 | $2.709M | 1.1% | $1.29 * | $0.88 | 0.0% | COM NEW | 70261F202 |
| CMPS | COMPASS PATHWAYS PLC | 388,287 | $2.679M | 1.1% | $6.90 | $6.90 | — | SPONSORED ADS | 20451W101 |
| AVTX | AVALO THERAPEUTICS INC | 130,000 | $2.361M | 1.0% | $18.16 * | $16.88 | 0.0% | COM NEW | 05338F306 |
| IVA | INVENTIVA SA | 300,000 | $1.395M | 0.6% | $4.65 | $4.65 | — | ADS | 46124U107 |
| ZBIO | ZENAS BIOPHARMA INC | 36,000 | $1.307M | 0.6% | $36.31 | — | — | Call | 98937L105 |
| TRAW | TRAWS PHARMA INC | 713,540 | $806K | 0.3% | $1.13 * | $2.22 | 0.0% | COM NEW | 68232V884 |
| NTLA | INTELLIA THERAPEUTICS INC | 81,000 | $728K | 0.3% | $8.99 | — | — | Call | 45826J105 |
| CLYM | CLIMB BIO INC | 100,000 | $400K | 0.2% | $4.00 * | $2.40 | 0.0% | COM | 28658R106 |